Skip to main content
. 2019 May 30;18(2):1089–1098. doi: 10.3892/ol.2019.10413

Figure 2.

Figure 2.

The actuarial cancer-specific survival and hazard rate of patients. (A) Actuarial cancer-specific survival of all patients in the cohort. (B) Hazard rate of NSCLC-associated mortality for all patients in the cohort. (C) Actuarial cancer-specific survival of patients who underwent different treatment strategies. (D) Hazard rate of NSCLC-associated mortality for patients who underwent different treatment strategies. NSCLC, non-small cell lung cancer; lob, lobectomy; sub, sublobar resection; rad, radiation; obs, observation.